Richa Singh, Prashant Kumar, Rahul Chaudhary, Arun Kumar, Shiv Bahadur, Garima Garg
Richa Singh1*, Prashant Kumar2, Rahul Chaudhary3, Arun Kumar1, Shiv Bahadur4, Garima Garg5
1Parmarth College of Pharmacy, Byepass Road, Hapur, Uttar Pradesh, India - 245101.
2College of Pharmacy, Teerthanker Mahaveer University, Moradabad, Uttar Pradesh, India - 244001.
3Dr. K. N. Modi Institute of Pharmaceutical Education and Research, Modinagar, Uttar Pradesh, India – 201204.
4Institute of Pharmaceutical Research, GLA University, Mathura, Uttar Pradesh, India – 281406.
5Amrapali Institute of Pharmacy and Sciences, Haldwani, Uttarakhand, India - 263139.
Volume - 15,
Issue - 6,
Year - 2022
The present work deals with the development of a novel co-processed excipients using melt- granulation technique that would serve as an inbuilt multifunction adjuvant and can be used for the preparation of tablet as solid dosage form with poorly compressible drugs like Paracetamol, Diclofenac, and Ibuprofen etc. by direct compression method. In the formulation DCP (Dicalcium phosphate) and Potato Starch were used as a filler in 2:1 ratio; Croscarmellose as a superdisintegrant and 20% w/v PEG 6000 (polyethylene glycol) as a binder, to develop the co-processed excipient. This resulted in formation of co-processed agglomerates, which had exhibited better flowability, compressibility and compaction properties when compared to an individual excipient and/or the physical mixture of compounds. Being a poorly compressible drug, PCM (Paracetamol) was used as a model drug to prepare tablets. The finally developed tablet dosage form of PCM along with co-processed excipient, were subjected to Fourier Transform Infra-Red (FTIR) study to ensure the absence of any drug-excipient interaction. The dosage form was also evaluated for capping and lamination to assure the better compressibility profile. The surface characteristics of developed co-processed agglomerated mass was characterised using Scanning Electron Microscopy (SEM). From the results obtained, it was concluded that the co-processed excipient is superior in flowability and compression characteristics in comparison to the physical mixture of excipients and individual components both. FTIR studies explained that there is no drug-excipient interaction and SEM also shown the spherical shapes of the agglomerated mass proving the better flowability properties of co-processed excipients.
Cite this article:
Richa Singh, Prashant Kumar, Rahul Chaudhary, Arun Kumar, Shiv Bahadur, Garima Garg. Development and Characterization of Novel co-processed excipients to enhance compressibility profile for Formulation of Tablet Dosage Form. Research Journal of Pharmacy and Technology. 2022; 15(6):2547-1. doi: 10.52711/0974-360X.2022.00426
Richa Singh, Prashant Kumar, Rahul Chaudhary, Arun Kumar, Shiv Bahadur, Garima Garg. Development and Characterization of Novel co-processed excipients to enhance compressibility profile for Formulation of Tablet Dosage Form. Research Journal of Pharmacy and Technology. 2022; 15(6):2547-1. doi: 10.52711/0974-360X.2022.00426 Available on: https://rjptonline.org/AbstractView.aspx?PID=2022-15-6-30
1. Gregory T. Fabrice K. Bruno L. Brian C. Brigitte E et al. Microcrystalline cellulose, a direct compression binder in a quality bydesign environment-A review. International Journal of Pharmaceutics. 2014; 473:64-72. doi:10.1016/j.ijpharm.2014.06.055.
2. Bansal KA. Nachaegari KS et al. Coprocessed excipients for solid dosage forms. Pharmaceutical Technology. 2004; 28:52-64.
3. Garg N. Pandey P. Kaushik D. Dureja H et al. Development of novel multifunction directly compressible co-processed excipient by melt granulation technique. International Journal of Pharmaceutical Investigation. 2015; 5:266-74. doi: 10.4103/2230-973X.167692.
4. Tayel SA. Soliman II. Louis D et al. Formulation of Ketotifen Fumarate Fast-Melt Granulation Sublingual Tablet. AAPS Pharm Sci Tech. 2010; 11:679-85. doi: 10.1208/s12249-010-9425-9.
5. Malke S. Shidhaye S. Kadam V et al. Novel melt granulation using sugars for metoclopramide hydrochloride orally disintegrating tablet. Asian Journal of Pharmaceutical and Clinical Research, 2009; 2:68-72. doi.org/10.22159/ijpps.2017v9i1.15656.
6. Jivraj M. Martini LG. Thomson CM et al. An Overview of the Different Excipients useful for the Direct Compression of Tablets. PSTT. 2000; 3:58-63. doi: 10.12691/nnr-4-1-3
7. Gohel MC. Parikh RK. Brahmbhatt BK. Shah AR et al. Preparation and Assessment of Novel Coprocessed Superdisintegrant Consisting of Croscarmellose and Sodium Starch Glycolate. AAPS Pharm Sci Tech. 2007; 8:2-7.
8. Modliszewski JJ. Ballard AD et al. Coprocessed galactomannan-glucomannan. US Patent, 1996; 5498436.
9. Gohel MC. Jogani PD et al. Functionality testing of a multifunctional directly compressible adjuvant containing lactose, polyvinylpyrrolidone, and croscarmellose sodium. Pharmaceutical technology. 2002; 8:64-82.
10. Patel SS. Patel NM et al. Development of directly compressible co-processed excipient for dispersible tablets using 32 full factorial designs. International Journal of Pharmacy and Pharmaceutical Sciences. 2009; 1:125-48.
11. Mohanachandran PS. Sindhumol PG. Kiran TS et al. Superdisintegrants: An Overview. International Journal of Pharmaceutical Sciences Review and Research. 2011; 6:108.
12. Gordon MS. Rudraraju VS. Dani K. Chowhan Z et al. Effect of the mode of super disintegrant incorporation on dissolution in wet granulated tablets. J Pharm Sci. 1993; 82(2):220-6. doi: 10.1002/jps.2600820222.
13. Awasthi R. Deepak GG. Pawar V. Sharma G. Kulkarni GT et al. Development of directly compressible co-processed excipients for solid dosage forms. Der Pharmacia Lettre. 2010; 2:151-65.
14. Sherwood B. Joseph ZA. David S. Wilhelm B. Hans TK et al. Agglomerated particles including an active agent coprocessed with silicified microcrystalline cellulose. US Patent. 2010; 0215753.
15. Solanki HK. Basuri T. Thakkar J. Patel CA et al. Recent advances in granulation technology. International Journal of Pharmecutical Science Review and Research. 2010; 5:48-54.
16. Hauschild K. Picker K et al. Evaluation of a new coprocessed compound based on lactose and maize starch for tablet formulation. AAPS Pharm Sci. 2004; 6:1-12. doi: 10.1208/ps060216.